Biotech leaders outraged by planned deportation of rare disease patient

Biotech industry leaders have expressed outrage at reports that a patient who is receiving a life-saving therapy in the U.S. that is unavailable in her country is facing the threat of deportation.

Media reports indicate that ICE has sent Maria Isabel Bueso, who has mucopolysaccharidosis VI (MPS VI), a letter ordering

Read the full 509 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE